Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GILD | AMGN | BMY | VRTX | REGN |
| Company | Gilead Sciences Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 67.47 | 273.45 | 47.39 | 402.44 | 911.09 |
| High | 67.90 | 274.35 | 47.50 | 403.88 | 915.00 |
| Low | 65.09 | 267.24 | 44.37 | 393.00 | 876.75 |
| Last | 65.27 | 269.38 | 44.70 | 397.70 | 890.68 |
| Change | -1.81 | -3.63 | -4.16 | -3.06 | -15.86 |
| % Change | -2.70% | -1.33% | -8.51% | -0.76% | -1.75% |
| Volume | 15,171,900 | 1,794,000 | 45,069,000 | 787,600 | 576,500 |
| 20-Day Average Volume | 6,861,755 | 2,149,590 | 12,858,680 | 964,110 | 454,910 |
| Previous Close | 67.08 | 273.01 | 48.86 | 400.76 | 906.54 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 68.68 | 270.70 | 49.94 | 402.31 | 922.51 |
| 20-Day Raw Stochastic | 2.05% | 31.20% | 3.27% | 21.98% | 14.81% |
| 20-Day Relative Strength | 28.32% | 44.80% | 28.31% | 42.69% | 34.96% |
| Weighted Alpha | -23.73 | +9.12 | -34.75 | +14.87 | +11.12 |
| Today's Opinion | 100% Sell | 72% Sell | 88% Sell | 8% Buy | 8% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 88% Sell | 8% Buy | 24% Buy |
| Last Month's Opinion | 88% Sell | 24% Buy | 8% Sell | 56% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.35% since 04/18/24 | +2.52% since 04/18/24 | -7.45% since 04/18/24 | +1.07% since 04/18/24 | -0.37% since 04/18/24 |
| Low | 65.09 on 04/25/24 | 260.68 on 04/19/24 | 44.37 on 04/25/24 | 391.25 on 04/19/24 | 876.75 on 04/25/24 |
| High | 67.90 on 04/25/24 | 274.86 on 04/24/24 | 49.56 on 04/22/24 | 406.86 on 04/23/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | -10.07% since 03/25/24 | -4.07% since 03/25/24 | -14.45% since 03/25/24 | -4.41% since 03/25/24 | -7.33% since 03/25/24 |
| Low | 65.09 on 04/25/24 | 260.68 on 04/19/24 | 44.37 on 04/25/24 | 391.01 on 04/18/24 | 876.75 on 04/25/24 |
| High | 73.87 on 03/28/24 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 421.45 on 04/01/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | -18.65% since 01/25/24 | -13.18% since 01/25/24 | -9.90% since 01/25/24 | -7.50% since 01/25/24 | -6.13% since 01/25/24 |
| Low | 65.09 on 04/25/24 | 260.68 on 04/19/24 | 44.37 on 04/25/24 | 391.01 on 04/18/24 | 876.75 on 04/25/24 |
| High | 80.51 on 01/26/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -16.74% since 10/25/23 | -1.02% since 10/25/23 | -21.04% since 10/25/23 | +9.55% since 10/25/23 | +11.75% since 10/25/23 |
| Low | 65.09 on 04/25/24 | 249.70 on 10/31/23 | 44.37 on 04/25/24 | 341.90 on 11/16/23 | 769.19 on 10/27/23 |
| High | 87.86 on 01/19/24 | 329.72 on 02/05/24 | 55.29 on 10/26/23 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 81,266,176 | 144,488,960 | 90,596,128 | 102,789,152 | 97,762,816 |
| Shares Outstanding, K | 1,245,077 | 536,376 | 2,026,759 | 258,459 | 109,762 |
| Annual Sales | 27,116,000,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | 5,665,000,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 7,114,000,000 | 8,196,000,000 | 11,477,000,000 | 2,517,700,000 | 3,434,300,000 |
| Last Quarter Net Income | 1,429,000,000 | 767,000,000 | 1,762,000,000 | 968,800,000 | 1,159,600,000 |
| 60-Month Beta | 0.19 | 0.58 | 0.39 | 0.35 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.32 on 04/25/24 | 4.71 on 02/06/24 | -4.40 on 04/25/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
| Most Recent Dividend | 0.770 on 03/14/24 | 2.250 on 02/15/24 | 0.600 on 04/04/24 | N/A | N/A |
| Next Ex-Dividends Date | 03/14/24 | 05/16/24 | 04/04/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 9.98 | 14.64 | 6.51 | 29.82 | 24.12 |